Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Resting state functional connectivity patterns as biomarkers of treatment response to escitalopram in patients with major depressive disorder
Marieke Martens, Nicola Filippini, Catherine J. Harmer, et al.
Psychopharmacology (2021) Vol. 239, Iss. 11, pp. 3447-3460
Open Access | Times Cited: 31

Showing 1-25 of 31 citing articles:

MRI predictors of pharmacotherapy response in major depressive disorder
Andrew Gerlach, Helmet T. Karim, Marta Peciña, et al.
NeuroImage Clinical (2022) Vol. 36, pp. 103157-103157
Open Access | Times Cited: 41
Brain connectivity in major depressive disorder: a precision component of treatment modalities?
A. Tura, Roberto Goya‐Maldonado
Translational Psychiatry (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 24
Safety, tolerability, and clinical and neural effects of single-dose psilocybin in obsessive–compulsive disorder: protocol for a randomized, double-blind, placebo-controlled, non-crossover trial
Terence H. W. Ching, Rachael Grazioplene, Calvin Bohner, et al.
Frontiers in Psychiatry (2023) Vol. 14
Open Access | Times Cited: 15
Sustained attention alterations in major depressive disorder: A review of fMRI studies employing Go/No-Go and CPT tasks
Maria Chiara Piani, Eleonora Maggioni, Giuseppe Delvecchio, et al.
Journal of Affective Disorders (2022) Vol. 303, pp. 98-113
Closed Access | Times Cited: 20
Breakthroughs and challenges for generating brain network-based biomarkers of treatment response in depression
Sapolnach Prompiengchai, Katharine Dunlop
Neuropsychopharmacology (2024) Vol. 50, Iss. 1, pp. 230-245
Closed Access | Times Cited: 4
Effects of Canine-Assisted Intervention on Stress and Depression in Humans
Yu-Jin Song, Youngwook Jung, Yeon-Ju Choi, et al.
Journal of Animal Science and Technology (2025)
Open Access
Association between the functional brain network and antidepressant responsiveness in patients with major depressive disorders: a resting-state EEG study
Kang‐Min Choi, Hyeon-Ho Hwang, Chaeyeon Yang, et al.
Psychological Medicine (2025) Vol. 55
Closed Access
Abnormal Resting-State Functional Connectivity in Adolescent Depressive Episodes
Nana Liang, Zhenpeng Xue, Jianchang Xu, et al.
Psychiatry Research Neuroimaging (2025), pp. 111961-111961
Closed Access
Study protocol for identifying resting brain functional connectivity markers of response to continuous Theta Burst Stimulation and cathodal transcranial Direct Current Stimulation in patients with schizophrenia with persistent auditory hallucinations
Vanteemar S. Sreeraj, Nishant Goyal, Sonia Shenoy, et al.
Wellcome Open Research (2025) Vol. 9, pp. 137-137
Open Access
Predicting the treatment outcomes of major depressive disorder interventions with baseline resting-state functional connectivity: a meta-analysis
Yanyao Zhou, Na Dong, Letian Lei, et al.
BMC Psychiatry (2025) Vol. 25, Iss. 1
Open Access
Review: The use of functional magnetic resonance imaging (fMRI) in clinical trials and experimental research studies for depression
Vasileia Kotoula, Jennifer W. Evans, Claire Punturieri, et al.
Frontiers in Neuroimaging (2023) Vol. 2
Open Access | Times Cited: 10
Distinct MRI-based functional and structural connectivity for antidepressant response prediction in major depressive disorder
Xinyi Wang, Xue Li, Junneng Shao, et al.
Clinical Neurophysiology (2024) Vol. 160, pp. 19-27
Closed Access | Times Cited: 3
Hazard and health risk assessment of exposure to pharmaceutical active compounds via toxicological evaluation by zebrafish
Imen Ben Chabchoubi, Su Shiung Lam, Stacey Ellen Pane, et al.
Environmental Pollution (2022) Vol. 324, pp. 120698-120698
Closed Access | Times Cited: 16
Transcutaneous Electrical Cranial-Auricular Acupoint Stimulation Modulating the Brain Functional Connectivity of Mild-to-Moderate Major Depressive Disorder: An fMRI Study Based on Independent Component Analysis
Lifang Liao, Liulu Zhang, Jun Lv, et al.
Brain Sciences (2023) Vol. 13, Iss. 2, pp. 274-274
Open Access | Times Cited: 8
Electroencephalographic Network Topologies Predict Antidepressant Responses in Patients With Major Depressive Disorder
Yueheng Peng, Yang Huang, Baodan Chen, et al.
IEEE Transactions on Neural Systems and Rehabilitation Engineering (2022) Vol. 30, pp. 2577-2588
Open Access | Times Cited: 12
Frequency-resolved connectome alterations in major depressive disorder: A multisite resting fMRI study
Lei Wang, Qing Ma, Xiaoyi Sun, et al.
Journal of Affective Disorders (2023) Vol. 328, pp. 47-57
Closed Access | Times Cited: 6
Effects of escitalopram therapy on functional brain controllability in major depressive disorder
Feng Fang, Beata R. Godlewska, Raymond Y. Cho, et al.
Journal of Affective Disorders (2022) Vol. 310, pp. 68-74
Open Access | Times Cited: 9
Neuroimaging Correlates of Treatment Response with Psychedelics in Major Depressive Disorder: A Systematic Review
Sarah Kuburi, Anne-Marie Di Passa, Vanessa K. Tassone, et al.
Chronic Stress (2022) Vol. 6
Open Access | Times Cited: 9
Association of the delayed changes in glutamate levels and functional connectivity with the immediate network effects of S-ketamine
Lena Vera Danyeli, Zümrüt Duygu Şen, Lejla Čolić, et al.
Translational Psychiatry (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 5
Unveiling potential adverse events associated with escitalopram oxalate: A real-world analysis based FDA adverse event reporting system database
Ying Jiang, Yusi Cheng, Z Du, et al.
Journal of Psychopharmacology (2024) Vol. 38, Iss. 6, pp. 567-578
Closed Access | Times Cited: 1
Baseline patterns of resting functional connectivity within posterior default-mode intranetwork associated with remission to antidepressants in major depressive disorder
Yanxiang Ye, Chengyu Wang, Xiaofeng Lan, et al.
NeuroImage Clinical (2022) Vol. 36, pp. 103230-103230
Open Access | Times Cited: 7
A randomized controlled trial of desvenlafaxine-induced structural brain changes in the treatment of persistent depressive disorder
Ravi Bansal, David J. Hellerstein, Siddhant Sawardekar, et al.
Psychiatry Research Neuroimaging (2023) Vol. 331, pp. 111634-111634
Closed Access | Times Cited: 2
Resting state functional connectivity as a predictor of brief intervention response in adults with alcohol use disorder: A preliminary study
Sabrina K. Syan, Carly McIntyre‐Wood, Emily Vandehei, et al.
Alcohol Clinical and Experimental Research (2023) Vol. 47, Iss. 8, pp. 1590-1602
Open Access | Times Cited: 2
Association of executive function with suicidality based on resting-state functional connectivity in young adults with subthreshold depression
Je‐Yeon Yun, Soo‐Hee Choi, Susan Park, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 2
Study protocol for identifying resting brain functional connectivity markers of response to continuous Theta Burst Stimulation and cathodal transcranial Direct Current Stimulation in patients with schizophrenia with persistent auditory hallucinations
Vanteemar S. Sreeraj, Nishant Goyal, Sonia Shenoy, et al.
Wellcome Open Research (2024) Vol. 9, pp. 137-137
Open Access
Page 1 - Next Page

Scroll to top